Philanthropic partners invest US$60 million to support collaborative research to accelerate the discovery of next-generation antibiotics The Gates Foundation, Novo Nordisk Foundation, and Wellcome today awarded a total of US$60 million in new grant funding over the next three years to research teams around the world exploring novel approaches to antibiotic discovery to deal with […]
Ready-to-use preformed antibiotic loaded spacers for hip, knee and shoulder revisions Choice of Charnley and Müller hip spacer designs, and left and right geometries for each knee Keele, UK, 21 October 2025 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and […]
BLADE-VG2 trial will evaluate the safety and efficacy of STIMULAN VG to treat diabetic foot osteomyelitis BLADE-OPU2 will evaluate the safety and efficacy of STIMULAN VG to treat stage IV pressure ulcers Keele, UK, 7 February 2024 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management […]
COPENHAGEN, Denmark, Jan. 9, 2024 – The Novo Nordisk Foundation is committing up to USD 25 million to support the early-stage development of innovative tools to prevent, diagnose and treat the most dangerous drug-resistant bacterial infections. The three-year grant will go to the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), the leading global non-profit public-private partnership in this […]
Paratek’s successful commercialisation platform to advance novel therapies developed organically and through acquisitions Paratek adds ‘final-mile’ capabilities to AMR efforts COPENHAGEN, September 21, 2023 – With the closing of the acquisition of Paratek Pharmaceuticals, Inc. (“Paratek”), a commercial-stage biopharmaceutical company focused on the development and commercialisation of novel therapies for life-threatening diseases and other public health […]
